| Execution period | Three months from the date of vesting |
|---|
BSE filing, NSE: AJANTPHARM. Summary written from the filing by ALFA Finder's alert engine.
Ajanta Pharma Ltd: key numbers
- Share price
- ₹3,508.80
- Market cap
- ₹43,846 Cr
- Revenue (annual)
- ₹5,453 Cr
- Net profit (annual)
- ₹1,056 Cr
- P/E (TTM)
- 34.7×Sector 45.9×
- Promoter holding
- 63.47%-0.01% QoQ
- FII holding
- 7.62%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajanta Pharma Ltd
All →Ajanta Pharma Earnings Call Transcript: Key Takeaways
Ajanta Pharma posted robust revenue and PAT growth, primarily driven by a temporary US market upside. Management remains cautious as competition intensifies.
- Call
- Guides 18% growth
Ajanta Pharma Q2 FY27 Results: Net Profit ₹388.1 Cr, Up 49.2% YoY
Ajanta Pharma Ltd reported revenue from operations of ₹1,794 Cr (+32.5% YoY) and net profit of ₹388.1 Cr (+49.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹388.1 Cr · +49.2% YoY
Ajanta Pharma Share Pledge
Ajanta Pharma promoter Aayush Agrawal (trustee) created a pledge on 30,000 equity shares. The pledge was made as a top-up call due to share price reduction.
Ajanta Pharma Board Meeting Date
Ajanta Pharma has scheduled a Board meeting for 30 October 2026 to consider Q2/H1 2026 unaudited financial results. No material decision has been taken yet.
Ajanta Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Ajanta Pharma Share Pledge
Promoter Aayush Agrawal Trust created pledge on 4,60,000 Ajanta Pharma shares. The pledge secures an NCD issue in favor of CTL Trusteeship Ltd.
Other employee stock options announcements
All →Clean Max Enviro Energy Solutions Employee Stock Options
Clean Max allotted 3,320 equity shares to employees under its ESOS 2015, comprising 1,660 option exercises and 1,660 bonus shares. Exercise money is INR 1,660 at INR 1 per option, a negligible amount.
Prataap Snacks Employee Stock Options
Prataap Snacks allotted 2,337 equity shares to employees on exercise of stock appreciation rights under its 2018 plan. Paid-up capital rises to Rs 11.97 crore.
L&T Finance Employee Stock Options
L&T Finance Holdings allotted 52,876 equity shares to employees exercising options under the 2013 ESOP scheme. No cash consideration or price per share is stated in the filing.
Shriram Asset Management Company Employee Stock Options
Shriram AMC's NRC granted 4,28,433 stock options under its 2022 ESOP plan. Exercise price is at committee discretion, not less than face value, with no money realised yet.
- Execution
- 10 years from the date of vesting
Avalon Technologies Employee Stock Options
Avalon Technologies allotted 16,138 equity shares to employees on 30 October 2026 under its 2022 ESOP scheme. Paid-up capital rose by Rs 32,276 across the allotment.
Syrma SGS Technology Employee Stock Options
Syrma SGS granted 4,42,486 stock options under its ESOP Plan 2023, exercisable into equity shares of Rs. 10 each. Vesting is staggered over five years at market price.